MARKET RESEARCH STORE

Smoking Cessation - Data,

Analysis & Forecasts to 2023
In April 2013 the US Food & Drug Agency (FDA) announced its plan
to relax rules regarding the use and labelling of over-the-counter
nicotine replacement therapies.

Smoking Cessation - Data, Analysis &

Forecasts to 2023
Smoking Cessation - Data, Analysis & Forecasts till 2023'
Pharmaceutical, Commercial & Strategic Developments in the Global
Smoking Cessation Market 2013-2023
In April 2013 the US Food & Drug Agency (FDA) announced its plan
to relax rules regarding the use and labelling of over-the-counter
nicotine replacement therapies.
On April 1st 2013, FDA Commissioner Margaret A. Hamburg M.D.
stated, The agency heard from several public health groups that the
labelling for OTC NRT products may stop consumers who are trying

to quit smoking from using them. The FDA hopes the recommended
changes will allow more people to use these products effectively for
smoking cessation and that tobacco dependence will decline in this
country. Will new changes increase take-up of smoking cessation
products? This report tells you.
Read Full Report with TOC:
http://www.marketresearchstore.com/report/smokingcessation--data-analysis--forecasts-to-859
The global smoking cessation market is forecast to reach $4.4bn in
2023, but what will it be this year? Next year? and in 5 years time?
GMR Datas new smoking cessation report outlines the key factors
affecting the market across the forecast period 2013-2023. The

report outlines essential drivers and restraints in all key global

geographies.
Nicoderm and Habitrol are the primary NRT products on the market,
accounting for over 80% of the global NRT market revenue in 2013.
Bupropion and Varenicline are the major products in the
prescription drug segment of the smoking cessation market. But
what are the 5 key drivers of the global smoking cessation market?
1) Increased health care / health education in many
geographies
2) Adoption of smoking cessation products onto health
insurance policies
3) Increasing number of smoking cessation products emerging
onto the market

4) Emergence of e-cigarettes onto the global market

5) Over 1bn smokers worldwide
Buy copy of Report:
http://www.marketresearchstore.com/checkout/reportId/859/report
Type/0
This report analysis your market, in key geographic segments;
explains in which direction each key market will grow across the
next 10 years, and why. Can you afford to ignore this report?
Key challenges for you & your competition

The key challenges that must be faced in the smoking cessation

market include; a weak R&D pipeline, off putting side effects
affecting key smoking cessation drugs and the challenge of multiple
e-cigarette brands encroaching the traditional NRT marketplace.
Only by ordering this in-depth exclusive report will you have full
access to the unique findings. This information is not available
anywhere else. Find full details of these approved drugs alongside
key cancer drugs in their testing phases in this new GMR Data
report.
This report also breaks down the market in terms of current
smoking cessation drugs and products that occupy the market at
present; examining the key prescription and OTC drugs that drive
the market. In addition to this crucial information this report offers

analysis and opinion on current R&D in the smoking cessation

sector alongside in depth analysis of the emerging, global ecigarette market.
Discover exactly what the industry leaders are doing TODAY
Within GMR Datas Smoking Cessation - Data, Analysis & Forecasts
to 2023 we analyse the key cessation products and drugs in the
market currently and how they will perform across the next decade.
Our study focuses on the individual revenues of the top Smoking
Cessation products. With variable patents and the threat of
generics, how will these key products fare across the next decade?
ONLY THIS UNIQUE REPORT WILL TELL YOU

We also include analysis of key NRT (Nicotine Replacement

Therapies such as NicoDerm CQ; Nicotrol; Habitrol (Nicotinell) and
Nicorette. Also analysed are the prescription drugs for smoking
cessation, such as: Chantix (by Pfizer): Varenicline and Zyban /
Wellbutrin (by GSK): bupropion.
With assessment of the leading players in smoking cessation
including: Pfizer; GlaxoSmithKline (GSK); Novartis; Johnson &
Johnson (J&J); Perrigo; Sophomore and Extab plus 22nd Century
Group, Inc.
Read Full Report with TOC:
http://www.marketresearchstore.com/report/smokingcessation--data-analysis--forecasts-to-859

PLUS In-depth country analysis Discover which countries and

regions will drive the smoking cessation drugs market to 2023?
Prescription drugs in the smoking cessation have proved popular
and, to some extent, effective. However, side effects and
increasingly severe FDA warnings have put some potential
customers off. What this means is that there is still space in the
market for new pipeline drugs, with fewer side effects and greater
efficacy.
But how will these prescription markets develop? This report
will tell you - TODAY
Industry information sourced exclusively for this report. This
information is not available anywhere else

Utilising primary and secondary research sources, GMR Data have

interviewed leading smoking cessation specialists within big
pharma, R&D, wholesalers, distributors, marketeers and key
organisations. From these interviews we have selected original,
exclusive, transcribed interviews with leading specialists in their
field This information is not available anywhere else.
This GMR Data report is the single tool to equip you with the latest
trends in all regional markets and why all stakeholders demand
development of Smoking Cessation products. This report will arm
you with all you and your company require to develop, price, launch
and market a smoking cessation product.

With over 100+ pages, and over 85+ pages of charts, tables,
figures and graphs, this dedicated specialist report will ensure you
remain equipped and fully informed, to succeed in this competitive
market.

Table of Content
Pharmaceutical, Commercial, & Strategic Developments in the
Global Smoking Cessation Market
1 Executive Summary
1.1. Smoking Cessation Market Review
1.2. Chapter Breakdown
1.3. Research and Analysis Methods

2 Introduction to Smoking Cessation

2.1. Smoking Cessation Treatment Overview
2.1.1. Nicotine Replacement Therapy (NRT)
2.1.2. Non-NRT Therapy
2.2. Global Tobacco Consumption Prevalence, Trends & Impact
2.2.1. Prevalence of Death Caused due to Tobacco
2.2.2. Second-Hand Smoking
2.2.3. Increased Awareness of Health Implications in Relation to
Smoking
2.2.4. Enforcement of Bans on Tobacco Product Advertising &
Promotions
2.2.5. Increased Taxation
3 Smoking Cessation Market Forecasts
3.1. Global Smoking Cessation Market

3.1.1. Global Smoking Cessation Market

3.1.2. Global Prescription Drugs Smoking Cessation Market
4 Key Global Smoking Cessation Markets 2013-2023
4.1. The US Smoking Cessation Market - Set to Occupy 45-50% of
the Global Market Across 2013- 2023
4.2. The UK Smoking Cessation Market - How Will This Mature
Market Grow Through 2013-2023?
4.3. The France Smoking Cessation Market - How Much of the
Global Smoking Cessation Market Will France Occupy to 2023?
4.4. The German Smoking Cessation Market - Will Reduced German
Tobacco Consumption Drive The Smoking Cessation Market?
4.5. The Spanish Smoking Cessation Market - The Strictest AntiSmoking Laws in the EU, How Will This Affect The Spanish Smoking
Cessation Market?

4.6. The Italian Smoking Cessation Market - How Will Strong Ecigarette Sales Affect Other NRT Products in the Italian Smoking
Cessation Market?
4.7. The Japanese Smoking Cessation Market - Why Does GMR Data
Forecast a Low Growth Rate in the Japanese Smoking Cessation
Market?
4.8. The Rest of World Smoking Cessation Market - How Will
Emerging Markets, Such as India & China, Affect theGlobal Smoking
Cessation Market Across 2013-2023?
5 Nicotine Replacement Therapies (NRT) Market
5.1. NicoDerm CQ
5.2. Nicotrol
5.3.Habitrol (Nicotinell)
5.4.Nicorette

6 Prescription Drugs Smoking Cessation Market

6.1.Chantix (by Pfizer): Varenicline
6.2.Zyban / Wellbutrin (by GSK): bupropion
7 Leading Companies in the Global Smoking Cessation Market
7.1. Pfizer
7.2. GlaxoSmithKline (GSK)
7.3. Novartis
7.4. Johnson & Johnson (J&J)
7.5. Perrigo
7.6. Sophomore and Extab
7.7. 22nd Century Group, Inc.
8 SWOT Analysis of the Smoking Cessation Market

8.1. Strengths
8.1.1. FDA Relaxation in the NRT Market
8.1.2. Increased Insurance Cover for Smoking Cessation Products
8.1.3. Strong Mature Markets
8.2. Weaknesses
8.2.1. Weak R&D pipeline for the smoking cessation market
8.2.2. Side Effects to Current Drugs/Therapies on the Market
8.3. Opportunities
8.3.1. E-cigarettes
8.3.1.1. E-cigarettes Legal Status
8.3.1.2. E-cigarettes Background
8.3.1.3. Geographic Breakdown & Market Share for E-cigarettes
8.3.1.4. Market Forecast
8.3.1.5. E-cigarette Industry Regulation
8.3.2. Future Research on Drugs/Therapies Currently on the Market

8.3.3. Strong Emerging Markets

8.4. Threats
8.4.1. Pool of Smokers Greatly Reduced in Some Key Markets
8.4.2. New Drug / Product threat
9 Expert Interviews
9.1. Pfizer
9.2. Elder Pharmaceuticals
9.3. GlaxoSmithKline
Read Full Report/Request for Sample:
http://www.marketresearchstore.com/report/smoking-cessation-data-analysis--forecasts-to-859

About Us
MarketResearchStore.com is a single destination for all the
industry, company and country reports. We feature large
repository of latest industry reports, leading and niche company
profiles, and market statistics released by reputed private
publishers and public organizations.
Market Research Store
Address: Suite #8138, 3422 SW 15 Street, Deerfield Beach, Florida 33442, USA
Tel: +1-386-310-3803

Tel: +1-855-465-4651 (US/CAN TOLL FREE)

Email: sales@marketresearchstore.com

Web : http://www.marketresearchstore.com